Search research articles
Contact Us
Filters
Showing results (51-60 of 84) with videos related to
Page
of 9
Sort By:
Journal of Managed Care & Specialty Pharmacy
|
September 15, 2025
Cost-per-responder analysis of daratumumab, bortezomib, lenalidomide, and dexamethasone vs bortezomib, lenalidomide, and dexamethasone among transplant-eligible patients with newly diagnosed multiple myeloma
Santosh Gautam, Laura Morrison, Philippe Thompson-Leduc, et al.
Current Medical Research and Opinion
|
December 18, 2018
Real-world outcomes post-transition to once-every-3-months paliperidone palmitate in patients with schizophrenia within US commercial plans
Bruno Emond, Antoine C El Khoury, Charmi Patel, et al.
Journal of Medical Economics
|
February 23, 2024
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer
Christine M Bestvina, Dexter Waters, Laura Morrison, et al.
The Journal of Clinical Psychiatry
|
April 7, 2022
Economic Burden of Commercially Insured Patients With Major Depressive Disorder and Acute Suicidal Ideation or Behavior in the United States
Dominic Pilon, Cheryl Neslusan, Maryia Zhdanava, et al.
Current Medical Research and Opinion
|
December 12, 2018
The prospective economic impact of once monthly paliperidone palmitate versus oral atypical antipsychotics in Medicaid patients with schizophrenia
Antoine C El Khoury, Dominic Pilon, Laura Morrison, et al.
The Oncologist
|
July 31, 2024
Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancer
Mehmet A Bilen, Ibrahim Khilfeh, Carmine Rossi, et al.
Advances in Experimental Medicine and Biology
|
May 9, 2021
Multimodal Measurements of Brain Tissue Metabolism and Perfusion in a Neonatal Model of Hypoxic-Ischaemic Injury
Gemma Bale, Ajay Rajaram, Matthew Kewin, et al.
Journal of Health Economics and Outcomes Research
|
September 2, 2025
Healthcare Resource Use, Healthcare Costs, and Unmet Needs Among Patients Treated for EGFR-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
David Waterhouse, Iris Li, Laura Morrison, et al.
Pharmacoeconomics
|
May 27, 2021
Cluster Analysis of Care Pathways in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior in the USA
Maryia Zhdanava, Jennifer Voelker, Dominic Pilon, et al.
Journal of Medical Economics
|
April 21, 2026
Cost-per-responder analysis of TAR-200 versus other Food and Drug Administration-approved novel and generic treatments among patients with Bacillus Calmette-Guérin-unresponsive, high-risk, non-muscle-invasive bladder cancer with carcinoma in situ in the United States
Stephen Williams, Sang Cho, Laura Morrison, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 84) with videos related to
Sort By:
Page
of 9
Journal of Managed Care & Specialty Pharmacy
|
September 15, 2025
Cost-per-responder analysis of daratumumab, bortezomib, lenalidomide, and dexamethasone vs bortezomib, lenalidomide, and dexamethasone among transplant-eligible patients with newly diagnosed multiple myeloma
Santosh Gautam, Laura Morrison, Philippe Thompson-Leduc, et al.
Current Medical Research and Opinion
|
December 18, 2018
Real-world outcomes post-transition to once-every-3-months paliperidone palmitate in patients with schizophrenia within US commercial plans
Bruno Emond, Antoine C El Khoury, Charmi Patel, et al.
Journal of Medical Economics
|
February 23, 2024
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer
Christine M Bestvina, Dexter Waters, Laura Morrison, et al.
The Journal of Clinical Psychiatry
|
April 7, 2022
Economic Burden of Commercially Insured Patients With Major Depressive Disorder and Acute Suicidal Ideation or Behavior in the United States
Dominic Pilon, Cheryl Neslusan, Maryia Zhdanava, et al.
Current Medical Research and Opinion
|
December 12, 2018
The prospective economic impact of once monthly paliperidone palmitate versus oral atypical antipsychotics in Medicaid patients with schizophrenia
Antoine C El Khoury, Dominic Pilon, Laura Morrison, et al.
The Oncologist
|
July 31, 2024
Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancer
Mehmet A Bilen, Ibrahim Khilfeh, Carmine Rossi, et al.
Advances in Experimental Medicine and Biology
|
May 9, 2021
Multimodal Measurements of Brain Tissue Metabolism and Perfusion in a Neonatal Model of Hypoxic-Ischaemic Injury
Gemma Bale, Ajay Rajaram, Matthew Kewin, et al.
Journal of Health Economics and Outcomes Research
|
September 2, 2025
Healthcare Resource Use, Healthcare Costs, and Unmet Needs Among Patients Treated for EGFR-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
David Waterhouse, Iris Li, Laura Morrison, et al.
Pharmacoeconomics
|
May 27, 2021
Cluster Analysis of Care Pathways in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior in the USA
Maryia Zhdanava, Jennifer Voelker, Dominic Pilon, et al.
Journal of Medical Economics
|
April 21, 2026
Cost-per-responder analysis of TAR-200 versus other Food and Drug Administration-approved novel and generic treatments among patients with Bacillus Calmette-Guérin-unresponsive, high-risk, non-muscle-invasive bladder cancer with carcinoma in situ in the United States
Stephen Williams, Sang Cho, Laura Morrison, et al.
Page
of 9